Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Environmental Science & Technology|September 14, 2017
Can Toxicokinetic and Toxicodynamic Modeling Be Used to Understand and Predict Synergistic Interactions between Chemicals?Nina Cedergreen, Kristoffer Dalhoff, Dan Li, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|June 24, 2015
Prognostic value of PET/CT in patients with lymphoma treated with autologous stem cell transplantation for relapsed/refractory or high risk diseasePiero M Stefani, Ugo Salvadori, Michele Gottardi, et al.
Expert Opinion on Biological Therapy|January 30, 2023
Biological therapy in elderly patients with acute myeloid leukemiaGiulia Ciotti, Giovanni Marconi, Alessandra Sperotto, et al.
International Journal of Molecular Sciences|October 28, 2023
Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the DiseasesEdoardo Peroni, Michele Gottardi, Lucia D'Antona, et al.
Plos One|April 25, 2012
CXCL12 and [N33A]CXCL12 in 5637 and HeLa cells: regulating HER1 phosphorylation via calmodulin/calcineurinAntonella Rigo, Michele Gottardi, Ernesto Damiani, et al.
Experimental Hematology & Oncology|August 4, 2026
Spatially resolved transcriptomic profiling of myelofibrosis spleen reveals compartment specific niche programsEdoardo Peroni, Marco Pizzi, Marco Basso, et al.
Haematologica|November 5, 2002
Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpuraDino Veneri, Massimo Franchini, Michele Gottardi, et al.
Stem Cells (Dayton, Ohio)|May 13, 2011
Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophilsMarco A Cassatella, Federico Mosna, Alessandra Micheletti, et al.
European Journal of Haematology|May 21, 2011
A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemiaCristina Tecchio, Ilaria Nichele, Federico Mosna, et al.
Pageof 9